Antibiotic resistance in Staphylococcus aureus. Current status and future prospects

Area of Science:

• Microbiology
• Pharmacology
• Genetics

Background:

• Staphylococci pose significant public health challenges due to antibiotic resistance.
• Antibiotic targets in staphylococci include the cell envelope, ribosome, and nucleic acids.
• Novel drug targets like ClpP protease and FtsZ are emerging.

Purpose of the Study:

• To review the development of resistance to current antibiotics in staphylococci.
• To examine future prospects for novel antibiotics and informed drug combination strategies.

Main Methods:

• Review of scientific literature on staphylococcal antibiotic resistance mechanisms.
• Analysis of resistance development via horizontal gene transfer and chromosomal mutations.
• Examination of drug modification, efflux, target alteration, and bypass mechanisms.

Main Results:

• Antibiotic resistance in staphylococci arises from enzymatic inactivation, target modification, drug efflux, and target bypass.
• Resistance develops through mobile genetic elements (plasmids, transposons) or chromosomal mutations.
• Mechanisms include altered drug targets, derepressed efflux pumps, and changes in cell wall/membrane permeability.

Conclusions:

• A comprehensive understanding of resistance mechanisms is crucial for combating staphylococcal infections.
• Future strategies involve developing new antibiotics and optimizing the use of drug combinations.
• Informed antibiotic use is essential to mitigate the growing threat of antimicrobial resistance.